222110 — Pangen Biotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Pangen Biotech, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	18,639	23,901	838	45.4	11,430
Net Total Accounts Receivable
Net Total Receivables	874	1,809	1,032	2,525	3,281
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	24,092	31,154	8,576	9,843	20,768
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	6,029	6,748	6,608	6,240	5,805
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	36,309	43,277	20,674	20,741	30,545
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	20,091	19,886	1,130	5,711	2,899
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	22,098	22,179	3,454	8,175	5,636
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	14,211	21,098	17,219	12,566	24,909
Total Liabilities & Shareholders' Equity	36,309	43,277	20,674	20,741	30,545
Total Common Shares Outstanding